GRPR and Familial prostate cancer: Moreover, GRPR overexpression has been found in a large spectrum of human cancers including small-cell lung carcinoma, breast, stomach, colon and prostate cancer which renders it an appealing target for the development of novel peptide based radiopharmaceuticals for oncological applications (52).